Dihydropteridinone infusion solution having a long shelf life

Disclosed is an aqueous infusible or injectable solution containing a dihydropteridinone derivative of formula (I), or a tautomer, racemate, enantiomer, or diastereomer thereof, wherein the substituents are as defined in the specification, and a physiologically acceptable acid or mix of acids which...

Full description

Saved in:
Bibliographic Details
Main Authors TRAULSEN, FRIDTJOF, MOHR, DETLEF, VEIT, CLAUS
Format Patent
LanguageEnglish
Published 24.12.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed is an aqueous infusible or injectable solution containing a dihydropteridinone derivative of formula (I), or a tautomer, racemate, enantiomer, or diastereomer thereof, wherein the substituents are as defined in the specification, and a physiologically acceptable acid or mix of acids which dissolve the main compound and act as a stabilizer. Also disclosed is the use of the above solution for treating tumoral diseases, infections, inflammatory and autoimmune diseases.
Bibliography:Application Number: NZ20050553815